方达控股与韩国GCCL达成战略合作,共同加强全球临床试验服务能力

新浪财经
Sep 24

来源:市场资讯(来源:智远资讯)【2025年9月24日,美国宾夕法尼亚州】方达控股与韩国GCCL宣布,于9月23日签署战略备忘录(MOU),以加强双方在全球临床试验市场的影响力。GCCL是韩国领先的临床试验样本分析提供商,方达控股可提供从临床前到临床服务一站式解决方案。此次合作旨在充分发挥双方服务与实验室网络优势,提升在美国及亚太地区(APAC)的竞争力,推动双方共同发展。在签约仪式上,两家公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10